SCHEMBL6968971

SCHEMBL6968971

CC(C)(C)OC(=O)N[C@H]1CCN(Cc2cccnc2)C1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 4/20 0.57
SIGMAR1 Q99720 1/20 0.54
DRD4 P21917 1/20 0.51
CHRM2 P08172 1/20 0.51
CHRM1 P11229 1/20 0.51
CHRM3 P20309 1/20 0.51
MAPK1 P28482 2/20 0.49
SLC6A5 Q9Y345 1/20 0.49
CXCR4 P61073 1/20 0.48
KDM4E B2RXH2 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KCNA3 P22001 1/20 0.47
KDM4D Q6B0I6 2/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
MCHR1 Q99705 1/20 0.46
AKT1 P31749 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15033052 0.87 SIGMAR1 (0.60) NPY5RSIGMAR1DRD4CHRM2CHRM1
SCHEMBL178929 0.87 KMT2A (0.63) SIGMAR1DRD4KMT2AL3MBTL1KCNA3
SCHEMBL2241423 0.87 KMT2A (0.63) SIGMAR1DRD4KMT2AL3MBTL1KCNA3
SCHEMBL2241424 0.87 KMT2A (0.63) SIGMAR1DRD4KMT2AL3MBTL1KCNA3
SCHEMBL16200816 0.85 SIGMAR1 (0.52) NPY5RSIGMAR1DRD4CHRM2CHRM1
SCHEMBL16200832 0.84 SIGMAR1 (0.52) NPY5RSIGMAR1DRD4CHRM2CHRM1
SCHEMBL7656471 0.83 SIGMAR1 (0.65) SIGMAR1DRD4CHRM2CHRM1CHRM3
SCHEMBL10135613 0.83 MCHR1 (0.51) NPY5RMCHR1
SCHEMBL10135593 0.83 MCHR1 (0.51) NPY5RMCHR1
SCHEMBL1412221 0.83 KMT2A (0.58) SIGMAR1DRD4KDM4EKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed